Panelists discuss how various assessment tools like the IGA, EASI score, and BSA are used to determine the severity of atopic dermatitis and document findings for insurance purposes.
Polling on Atopic Dermatitis Diagnostic Challenges
Primary care physicians report key challenges in diagnosing atopic dermatitis:
Difficulty differentiating from other skin conditions (60%)
Limited access to dermatology support (47%)
Lack of time for thorough assessment (37%)
Insufficient knowledge about the disease
Carolyn Stolte, CRNP, emphasized time constraints as a major barrier with 15-minute appointments covering multiple health concerns
Carolyn Stolte, CRNP, highlighted that skin conditions often receive lower priority compared to cardiac, renal, and other systemic issues
Importance noted of recognizing how atopic dermatitis impacts quality of life, mental health, sleep, and potentially other health parameters such as blood pressure
Determining Atopic Dermatitis Severity
Key severity assessment tools discussed:
IGA (Investigator’s Global Assessment): most important for documentation
EASI (Eczema Area and Severity Index): calculator available online
BSA (body surface area), using rule of nines
SCORAD (combines BSA, intensity, symptoms, itch, and sleep)
POEM (patient-reported symptom questionnaire)
DLQI (Dermatology Life Quality Index)
For insurance coverage documentation, requirements typically include:
IGA score of 3-4
BSA of at least 10%
EASI score of approximately 16%
Shawn Kwatra, MD, highlighted the Numeric Rating Scale (NRS) as a quick 10- to 20-second assessment tool:
Asks patients to rate worst itch in past 24 hours on scale of 0-10
Scores ≥7 correlate with severe disruptions in quality of life, sleep issues, and higher rates of anxiety/depression
Severity Assessment Details
IGA scoring system detailed:
0 = Clear (no inflammatory signs)
1 = Almost clear (barely perceptible erythema, papules, slight lichenification)
2 = Mild (slight but definite erythema, papules, or lichenification)
3 = Moderate (clearly perceptible erythema, papulation, or lichenification)
4 = Severe (marked erythema, papulation, lichenification; widespread with possible oozing, crusting, infection)
BSA calculation using rule of nines explained:
Palm = 1%
Head and neck = 9%
Upper limbs = 9% each
Trunk = 36%
Genitalia = 1%
Lower limbs = 18% each
Both panelists emphasized documentation requirements for therapeutic coverage